Terms: = Bone cancer AND FLT4, FLT41, 2324, ENSG00000037280, P35916, VEGFR3, PCL AND Treatment
48 results:
1. bone mimetic environments support engineering, propagation, and analysis of therapeutic response of patient-derived cells, ex vivo and in vivo.
Paindelli C; Parietti V; Barrios S; Shepherd P; Pan T; Wang WL; Satcher RL; Logothetis CJ; Navone N; Campbell MT; Mikos AG; Dondossola E
Acta Biomater; 2024 Apr; 178():83-92. PubMed ID: 38387748
[TBL] [Abstract] [Full Text] [Related]
2. 3D-Printed Magnesium Peroxide-Incorporated Scaffolds with Sustained Oxygen Release and Enhanced Photothermal Performance for Osteosarcoma Multimodal treatments.
Haixia X; Peng Z; Jiezhao L; Huiling G; Xie C; Yihan W; Yanglei J; Li J; Wang C; Wenning X; Lixin Z; Liu C
ACS Appl Mater Interfaces; 2024 Feb; 16(8):9626-9639. PubMed ID: 38372238
[TBL] [Abstract] [Full Text] [Related]
3. [A Case of Gastric cancer with Pulmonary Carcinomatous Lymphangitis and Disseminated Carcinomatosis of the bone Marrow Responding to S-1 plus Cisplatin Chemotherapy].
Otsuka N; Shirayama K
Gan To Kagaku Ryoho; 2023 Dec; 50(12):1319-1321. PubMed ID: 38247072
[TBL] [Abstract] [Full Text] [Related]
4. flt4 as a marker for predicting prognostic risk of refractory acute myeloid leukemia.
Lee JY; Lee SE; Han AR; Lee J; Yoon YS; Kim HJ
Haematologica; 2023 Nov; 108(11):2933-2945. PubMed ID: 37317880
[TBL] [Abstract] [Full Text] [Related]
5. A nanodrug combining CD47 and sonodynamic therapy efficiently inhibits osteosarcoma deterioration.
Gong M; Huang Y; Feng H; Lin J; Huang A; Hu J; Tang Q; Zhu X; Han S; Lu J; Wang J
J Control Release; 2023 Mar; 355():68-84. PubMed ID: 36682726
[TBL] [Abstract] [Full Text] [Related]
6. Dual-Modal Imaging and Synergistic Spinal Tumor Therapy Enabled by Hierarchical-Structured Nanofibers with Cascade Release and Postoperative Anti-adhesion.
Qian J; Su L; He J; Ruan R; Wang J; Wang Z; Xiao P; Liu C; Cao Y; Li W; Zhang J; Song J; Yang H
ACS Nano; 2022 Oct; 16(10):16880-16897. PubMed ID: 36136320
[TBL] [Abstract] [Full Text] [Related]
7. Oral Progenitor Cell Line-Derived Small Extracellular Vesicles as a treatment for Preferential Wound Healing Outcome.
Knight R; Board-Davies E; Brown H; Clayton A; Davis T; Karatas B; Burston J; Tabi Z; Falcon-Perez JM; Paisey S; Stephens P
Stem Cells Transl Med; 2022 Aug; 11(8):861-875. PubMed ID: 35716044
[TBL] [Abstract] [Full Text] [Related]
8. Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage.
Fernández de Larrea C; Kyle R; Rosiñol L; Paiva B; Engelhardt M; Usmani S; Caers J; Gonsalves W; Schjesvold F; Merlini G; Lentzch S; Ocio E; Garderet L; Moreau P; Sonneveld P; Badros A; Gahrton G; Goldschmidt H; Tuchman S; Einsele H; Durie B; Wirk B; Musto P; Hayden P; Kaiser M; Miguel JS; Bladé J; Rajkumar SV; Mateos MV
Blood Cancer J; 2021 Dec; 11(12):192. PubMed ID: 34857730
[TBL] [Abstract] [Full Text] [Related]
9. Magnetic bioactive glasses/Cisplatin loaded-chitosan (CS)-grafted- poly (ε-caprolactone) nanofibers against bone cancer treatment.
Amini Z; Rudsary SS; Shahraeini SS; Dizaji BF; Goleij P; Bakhtiari A; Irani M; Sharifianjazi F
Carbohydr Polym; 2021 Apr; 258():117680. PubMed ID: 33593554
[TBL] [Abstract] [Full Text] [Related]
10. Targeted micelles with chemotherapeutics and gene drugs to inhibit the G1/S and G2/M mitotic cycle of prostate cancer.
Zhang Y; Wang Y; Meng L; Huang Q; Zhu Y; Cui W; Cheng Y; Liu R
J Nanobiotechnology; 2021 Jan; 19(1):17. PubMed ID: 33422073
[TBL] [Abstract] [Full Text] [Related]
11. Cell Membrane-Inspired Polymeric Vesicles for Combined Photothermal and Photodynamic Prostate cancer Therapy.
Hu J; Luo H; Qu Q; Liao X; Huang C; Chen J; Cai Z; Bao Y; Chen G; Li B; Cui W
ACS Appl Mater Interfaces; 2020 Sep; 12(38):42511-42520. PubMed ID: 32897691
[TBL] [Abstract] [Full Text] [Related]
12.
Tuazon SA; Sandmaier BM; Gooley TA; Fisher DR; Holmberg LA; Becker PS; Lundberg SJ; Orozco JJ; Gopal AK; Till BG; Coffey DG; Nartea ME; Matesan MC; Pagel JM; Rajendran JG; Press OW; Bensinger WI; Green DJ
Bone Marrow Transplant; 2021 Jan; 56(1):202-209. PubMed ID: 32710011
[TBL] [Abstract] [Full Text] [Related]
13. Combinational delivery of anticancer drugs for osteosarcoma treatment using electrosprayed core shell nanocarriers.
Prasad SR; Jayakrishnan A; Kumar TSS
J Mater Sci Mater Med; 2020 May; 31(5):44. PubMed ID: 32367204
[TBL] [Abstract] [Full Text] [Related]
14. A facile way for development of three-dimensional localized drug delivery system for bone tissue engineering.
Farzin A; Etesami SA; Goodarzi A; Ai J
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110032. PubMed ID: 31546347
[TBL] [Abstract] [Full Text] [Related]
15. Pediatric lung adenocarcinoma presenting with brain metastasis: a case report.
De Martino L; Errico ME; Ruotolo S; Cascone D; Chiaravalli S; Collini P; Ferrari A; Muto P; Cinalli G; Quaglietta L
J Med Case Rep; 2018 Sep; 12(1):243. PubMed ID: 30172261
[TBL] [Abstract] [Full Text] [Related]
16. Light and shadows of a new technique: is photon total-skin irradiation using helical IMRT feasible, less complex and as toxic as the electrons one?
Buglione M; Spiazzi L; Urpis M; Baushi L; Avitabile R; Pasinetti N; Borghetti P; Triggiani L; Pedretti S; Saiani F; Fiume A; Greco D; Ciccarelli S; Polonini A; Moretti R; Magrini SM
Radiat Oncol; 2018 Aug; 13(1):158. PubMed ID: 30157892
[TBL] [Abstract] [Full Text] [Related]
17. Fulminant primary cardiac lymphoma with sudden cardiac death: A case report and brief review.
Cheng JF; Lee SH; Hsu RB; Yu SC; Shun CT; Huang PS; Chen YH; Lee CM
J Formos Med Assoc; 2018 Oct; 117(10):939-943. PubMed ID: 29681417
[TBL] [Abstract] [Full Text] [Related]
18. Therapeutic pcl scaffold for reparation of resected osteosarcoma defect.
Palamà IE; Arcadio V; D'Amone S; Biasiucci M; Gigli G; Cortese B
Sci Rep; 2017 Oct; 7(1):12672. PubMed ID: 28978922
[TBL] [Abstract] [Full Text] [Related]
19. Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register.
Nahi H; Genell A; Wålinder G; Uttervall K; Juliusson G; Karin F; Hansson M; Svensson R; Linder O; Carlson K; Björkstrand B; Kristinsson SY; Mellqvist UH; Blimark C; Turesson I
Eur J Haematol; 2017 Sep; 99(3):216-222. PubMed ID: 28544116
[TBL] [Abstract] [Full Text] [Related]
20. Design of polyaspartic acid peptide-poly (ethylene glycol)-poly (ε-caprolactone) nanoparticles as a carrier of hydrophobic drugs targeting cancer metastasized to bone.
Liu J; Zeng Y; Shi S; Xu L; Zhang H; Pathak JL; Pan Y
Int J Nanomedicine; 2017; 12():3561-3575. PubMed ID: 28507436
[TBL] [Abstract] [Full Text] [Related]
[Next]
